Our preprint Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications was posted today.
Read the preprint. This is a preprint and has not yet been peer reviewed.
This announcement also appeared on the lab’s original News page.